2026 Global: Magnetic Resonance Imaging (Mri) Compatible Iv Infusion Pumps Market -Competitive Review (2032) report
Description
The 2026 Global: Magnetic Resonance Imaging (Mri) Compatible Iv Infusion Pumps Market-Competitive Review (2032) report features the global market size and projected growth/decline data for the period 2021 and 2032. The report primarily provides an examination of the business strategies for the ten largest global companies in the market and how their strategies differ.
The MRI-compatible IV infusion pumps market is dominated by ten major manufacturers that collectively drive innovation and market growth in this specialized medical device sector. IRadimed Corporation, headquartered in Winter Park, Florida, United States, stands as the world's only provider of non-magnetic IV infusion pump systems specifically designed for use during MRI procedures, securing its position as a market leader. Baxter International Inc., based in Deerfield, Illinois, United States, leverages its extensive research and development capabilities and safety enhancements to maintain a formidable market presence. B. Braun SE, located in Melsungen, Germany, strengthens its competitive advantage through digital health capabilities and an increasingly expansive global footprint. Becton, Dickinson and Company (BD), headquartered in Franklin Lakes, New Jersey, United States, excels with a robust and varied product portfolio encompassing advanced medical devices and strategic alliances. Fresenius Kabi AG, based in Bad Homburg, Germany, capitalizes on innovation and digitalization strategies to address distinct clinical needs and improve interoperability among its solutions.
Medtronic plc, headquartered in Dublin, Ireland, represents a significant player in the broader infusion pump market with substantial resources dedicated to MRI-compatible technologies. ICU Medical Inc., located in San Clemente, California, United States, enhances its market position by diversifying its product offerings in syringe and ambulatory infusion systems while increasing digital integration. Arcomed AG, based in Burgdorf, Switzerland, continues to develop innovative MRI-compatible infusion solutions for clinical applications. Smiths Medical, a division of Smiths Group plc headquartered in London, United Kingdom, maintains an active presence in the MRI-compatible infusion pump market through its specialized medical device offerings.
These ten companies collectively represent the primary competitive landscape of the MRI-compatible IV infusion pumps market, which was valued at approximately $143.1 million in 2023 and is projected to reach $227.1 million by 2030, exhibiting a compound annual growth rate of 6.4 percent. North America remains the largest market geographically, while the Asia-Pacific region emerges as the fastest-growing market for these devices. The market's expansion is driven by increasing demand in hospitals, ambulatory surgical centers, and diagnostic imaging facilities where MRI procedures require specialized infusion delivery systems. These manufacturers prioritize technological differentiation, regulatory approvals, and strategic expansions to enhance their market positions and meet evolving clinical requirements for safe and effective drug delivery during magnetic resonance imaging procedures.
The MRI-compatible IV infusion pumps market is dominated by ten major manufacturers that collectively drive innovation and market growth in this specialized medical device sector. IRadimed Corporation, headquartered in Winter Park, Florida, United States, stands as the world's only provider of non-magnetic IV infusion pump systems specifically designed for use during MRI procedures, securing its position as a market leader. Baxter International Inc., based in Deerfield, Illinois, United States, leverages its extensive research and development capabilities and safety enhancements to maintain a formidable market presence. B. Braun SE, located in Melsungen, Germany, strengthens its competitive advantage through digital health capabilities and an increasingly expansive global footprint. Becton, Dickinson and Company (BD), headquartered in Franklin Lakes, New Jersey, United States, excels with a robust and varied product portfolio encompassing advanced medical devices and strategic alliances. Fresenius Kabi AG, based in Bad Homburg, Germany, capitalizes on innovation and digitalization strategies to address distinct clinical needs and improve interoperability among its solutions.
Medtronic plc, headquartered in Dublin, Ireland, represents a significant player in the broader infusion pump market with substantial resources dedicated to MRI-compatible technologies. ICU Medical Inc., located in San Clemente, California, United States, enhances its market position by diversifying its product offerings in syringe and ambulatory infusion systems while increasing digital integration. Arcomed AG, based in Burgdorf, Switzerland, continues to develop innovative MRI-compatible infusion solutions for clinical applications. Smiths Medical, a division of Smiths Group plc headquartered in London, United Kingdom, maintains an active presence in the MRI-compatible infusion pump market through its specialized medical device offerings.
These ten companies collectively represent the primary competitive landscape of the MRI-compatible IV infusion pumps market, which was valued at approximately $143.1 million in 2023 and is projected to reach $227.1 million by 2030, exhibiting a compound annual growth rate of 6.4 percent. North America remains the largest market geographically, while the Asia-Pacific region emerges as the fastest-growing market for these devices. The market's expansion is driven by increasing demand in hospitals, ambulatory surgical centers, and diagnostic imaging facilities where MRI procedures require specialized infusion delivery systems. These manufacturers prioritize technological differentiation, regulatory approvals, and strategic expansions to enhance their market positions and meet evolving clinical requirements for safe and effective drug delivery during magnetic resonance imaging procedures.
Table of Contents
32 Pages
- 1.0 Scope of Report and Methodology
- 2.0 Market SWOT Analysis and Players
- 2.1 Market Definition
- 2.2 Market Segments
- 2.3 Market Strengths
- 2.4 Market Weaknesses
- 2.5 Market Threats
- 2.6 Market Opportunities
- 2.7 Major Players
- 3.0 Competitive Analysis
- 3.1 Market Player 1
- 3.2 Market Player 2
- 3.3 Market Player 3
- 3.4 Market Player 4
- 3.5 Market Player 5
- 3.6 Market Player 6
- 3.7 Market Player 7
- 3.8 Market Player 8
- 3.9 Market Player 9
- 3.10 Market Player 10
- 4.0 Comparative Business Strategies
- 4.1 Comparative Business Strategies of Player 1 and 2
- 4.2 Comparative Business Strategies of Player 1 and 3
- 4.3 Comparative Business Strategies of Player 1 and 4
- 4.4 Comparative Business Strategies of Player 2 and 3
- 4.5 Comparative Business Strategies of Player 2 and 4
- 4.6 Comparative Business Strategies of Player 3 and 4
- 5.0 Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
